HSBC Holdings’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-14,673
Closed -$49K 3131
2021
Q1
$49K Sell
14,673
-45,294
-76% -$162K ﹤0.01% 2669
2020
Q4
$203K Sell
59,967
-19,433
-24% -$80K ﹤0.01% 2813
2020
Q3
$323K Buy
79,400
+1,005
+1% +$3.82K ﹤0.01% 2207
2020
Q2
$265K Buy
78,395
+27,700
+55% +$80.7K ﹤0.01% 2191
2020
Q1
$117K Buy
50,695
+40,492
+397% +$111K ﹤0.01% 2445
2019
Q4
$37K Sell
10,203
-210
-2% -$1.7K ﹤0.01% 2984
2019
Q3
$86K Buy
+10,413
New +$84.2K ﹤0.01% 2994
2017
Q1
Sell
-13,351
Closed -$59K 2676
2016
Q4
$59K Buy
+13,351
New +$56K ﹤0.01% 2657

Other funds holding SPPI

HSBC Holdings's SPPI Position: Q2 2021 in Review

HSBC Holdings sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q2 2021, closing a stake of 14,673 shares — an estimated $49K sold.

HSBC Holdings first reported a position in SPPI in Q4 2016 and held it in 8 quarters. The position peaked at $323K in Q3 2020. 156 funds tracked by Wall St. Rank hold SPPI as of Q2 2021.

  • HSBC Holdings reported no remaining Spectrum Pharmaceuticals Inc position as of Q2 2021 after selling out during the quarter.
  • HSBC Holdings sold 14,673 Spectrum Pharmaceuticals Inc shares in Q2 2021, an estimated $49K.
  • HSBC Holdings first reported a position in Spectrum Pharmaceuticals Inc in Q4 2016 and held it in 8 quarters.
  • HSBC Holdings's Spectrum Pharmaceuticals Inc position peaked at $323K in Q3 2020.
  • 156 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q2 2021.

Based on HSBC Holdings's 13F filing for Q2 2021, filed 13 Aug 2021.